Fortress Biotech (FBIO) Gross Margin (2016 - 2025)
Historic Gross Margin for Fortress Biotech (FBIO) over the last 11 years, with Q3 2025 value amounting to 67.36%.
- Fortress Biotech's Gross Margin fell 20800.0% to 67.36% in Q3 2025 from the same period last year, while for Sep 2025 it was 67.64%, marking a year-over-year decrease of 28500.0%. This contributed to the annual value of 63.8% for FY2024, which is 91100.0% down from last year.
- According to the latest figures from Q3 2025, Fortress Biotech's Gross Margin is 67.36%, which was down 20800.0% from 69.91% recorded in Q2 2025.
- Fortress Biotech's 5-year Gross Margin high stood at 88.73% for Q4 2023, and its period low was 47.04% during Q3 2021.
- In the last 5 years, Fortress Biotech's Gross Margin had a median value of 61.55% in 2024 and averaged 62.15%.
- Its Gross Margin has fluctuated over the past 5 years, first crashed by -209800bps in 2021, then skyrocketed by 357800bps in 2023.
- Quarter analysis of 5 years shows Fortress Biotech's Gross Margin stood at 47.88% in 2021, then increased by 11bps to 52.95% in 2022, then soared by 68bps to 88.73% in 2023, then fell by -22bps to 69.05% in 2024, then fell by -2bps to 67.36% in 2025.
- Its Gross Margin stands at 67.36% for Q3 2025, versus 69.91% for Q2 2025 and 63.54% for Q1 2025.